CD11c+CD8α+ dendritic cells promote protective immunity to respiratory infection with Bordetella pertussis

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 400-410

  Dunne, Pádraic J ^a   Moran, Barry ^a   Cummins, Robert C ^b   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD103 ANTIGEN; CD8ALPHA ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; CD8 ANTIGEN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BORDETELLA PERTUSSIS; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL INFILTRATION; CELL MATURATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNITY; LUNG; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TRANSPORT; RESPIRATORY TRACT INFECTION; TH1 CELL; UPPER RESPIRATORY TRACT; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DISEASE MODEL; IMMUNOLOGY; LYMPH NODE; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD8; BORDETELLA PERTUSSIS; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; LUNG; LYMPH NODES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; WHOOPING COUGH;

EID: 68949149048     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900169     Document Type: Article

References (56)

1. Cherry, J. D. 2006. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 25: 361-362.
2. Cherry, J. D. 1999. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin. Infect. Dis. 28(Suppl. 2): S107-S111.
3. Cherry, J. D. 2007. Immunity to pertussis. Clin. Infect. Dis. 44: 1278-1279.
4. Byrne, P., P. McGuirk, S. Todryk, and K. H. G. Mills. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34: 2579-2588.
5. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61: 399-410.
6. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. G. Mills. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-γ receptor or immunoglobulin μ chain genes. J. Exp. Med. 186: 1843-1851.
7. Fennelly, N. K., F. Sisti, S. C. Higgins, P. J. Ross, H. van der Heide, F. R. Mooi, A. Boyd, and K. H. Mills. 2008. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect. Immun. 76: 1257-1266.
8. McGuirk, P., C. McCann, and K. H. G. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231.
9. Lambrecht, B. N., J.-B. Prins, and H. C. Hoogsteden. 2001. Lung dendritic cells and host immunity to infection. Eur. Respir. J. 18: 692-704.
10. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
11. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170: 4437-4440.
12. + T cells. Nat. Immunol. 8: 1060-1066.
13. Suss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183: 1789-1796.
14. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176: 47-58.
15. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159: 565-573.
16. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell sub-populations identified. J. Exp. Med. 184: 1953-1962.
17. Hochrein, H., B. Schlatter, M. O'Keeffe, C. Wagner, F. Schmitz, M. Schiemann, S. Bauer, M. Suter, and H. Wagner. 2004. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 101: 11416-11421.
18. Raftery, M. J., F. Winau, T. Giese, S. H. Kaufmann, U. E. Schaible, and G. Schonrich. 2008. Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur. J. Immunol. 38: 668-679.
19. Kang, H.-K., M. Liu, and S. K. Datta. 2007. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory t cells and contraction of inflammatory Th17 cells. J. Immunol. 178: 7849-7858.
20. Gilliet, M., and Y.-J. Liu. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195: 695-704.
21. Brawand, P., D. R. Fitzpatrick, B. W. Greenfield, K. Brasel, C. R. Maliszewski, and T. De Smedt. 2002. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 169: 6711-6719.
22. Annacker, O., J. L. Coombes, V. Malmstrom, H. H. Uhlig, T. Bourne, B. Johansson-Lindbom, W. W. Agace, C. M. Parker, and F. Powrie. 2005. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202: 1051-1061.
23. + regulatory T cells via a TGF-β and retinoic acid dependent mechanism. J. Exp. Med. 204: 1757-1764.
24. + dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205: 2139-2149.
25. 7 integrin-positive epithelial dendritic cell population expressing langerin and tight junction proteins. J. Immunol. 176: 2161-2172.
26. + T cells. J. Immunol. 178: 6861-6866.
27. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66: 594-602.
28. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
29. + dendritic cells during infection with intracellular pathogens. Immunol. Lett. 114: 66-72.
30. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
31. + dendritic cells: tissue-dependent differences offset CD8α-related dendritic cell heterogeneity. Eur. J. Immunol. 33: 2007-2013.
32. - but not plasmacytoid dendritic cells. J. Exp. Med. 205: 1621-1634.
33. - dendritic cells in vivo. Eur. J. Immunol. 29: 3762-3767.
34. Pettersson, A., X. C. Wu, C. Ciumas, H. Lian, V. Chirsky, Y. M. Huang, B. Bjelke, H. Link, and B. G. Xiao. 2004. CD8α dendritic cells and immune protection from experimental allergic encephalomyelitis. Clin. Exp. Immunol. 137: 486-495.
35. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201: 981-991.
36. Brasel, K., T. De Smedt, J. L. Smith, and C. R. Maliszewski. 2000. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96: 3029-3039.
37. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
38. + subset. J. Immunol. 165: 1357-1363.
39. + dendritic cells are involved in enhancing herpes simplex virus type 1 latency. J. Virol. 82: 9870-9879.
40. + dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J. Immunol. 182: 4127-4136.
41. + dendritic cells in vivo. J. Exp. Med. 195: 683-694.
42. Hong, L., T. J. Webb, and D. S. Wilkes. 2007. Dendritic cell-T cell interactions: CD8aa expressed on dendritic cells regulates T cell proliferation. Immunol. Lett. 108: 174-178.
43. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-1041.
44. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159: 2222-2231.
45. Harshyne, L. A., S. C. Watkins, A. Gambotto, and S. M. Barratt-Boyes. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166: 3717-3723.
46. + dendritic cells is attributable to their ability to internalize dead cells. Immunology 107: 183-189.
47. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
48. Sigmundsdottir, H., and E. C. Butcher. 2008. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9: 981-987.
49. - dendritic cells and their in vivo trafficking. J. Leukocyte Biol. 75: 275-285.
50. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171: 3119-3127.
51. + T cells for key functions other than specific antibody production. J. Exp. Med. 191: 1841-1852.
52. Maraskovsky, E., E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack, and H. J. McKenna. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96: 878-884.
53. Evans, T. G., M. Hasan, L. Galibert, and D. Caron. 2002. The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults. Vaccine 21: 322-329.
54. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165: 566-572.
55. Freedman, R. S., S. Vadhan-Raj, C. Butts, C. Savary, B. Melichar, C. Verschraegen, J. J. Kavanagh, M. E. Hicks, L. B. Levy, J. K. Folloder, and M. E. Garcia. 2003. Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas. Clin. Cancer Res. 9: 5228-5237.
56. Chakravarty, P. K., A. Alfieri, E. K. Thomas, V. Beri, K. E. Tanaka, B. Vikram, and C. Guha. 1999. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res. 59: 6028-6032.